Organization · Private Equity
Athyrium Capital Management, LP
Athyrium Capital Management, LP is a specialized asset management firm focused on the global healthcare sector, investing in various financial instruments including royalties, structured credit, and equities.
Overview
What Athyrium Capital Management, LP does
What Athyrium Capital Management, LP is
Athyrium Capital Management, LP is a specialized asset management firm focused on the global healthcare sector, investing in various financial instruments including royalties, structured credit, and equities.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Founded
- Founded in 2008
- Approximate age
- About 18 years
- Structured capabilities
- Funder
- Last reviewed
- April 5, 2026
Official channels
Find Athyrium Capital Management, LP elsewhere
Open the official website or a supported primary organization account.
Capability profile
Athyrium Capital Management, LP as a funder
Investment thesis
Athyrium Capital Management focuses on investment opportunities in the healthcare and life sciences sectors, targeting commercial-stage companies with compelling products and differentiated services.
Focus narrative
Athyrium invests in a variety of asset classes within the healthcare sector, including public equity, private equity, fixed income, royalties, and other structured securities. The firm advises funds with over $4.6 billion of committed capital and typically invests up to $200 million per investment.
Value beyond capital
Athyrium provides strategic guidance and capital to its portfolio companies, leveraging its expertise in the healthcare sector to enhance value and drive growth.
Terms and economics
- Typical check
- $1,000,000–$200,000,000
Focus and fit
- Regions
- Global · North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 85
Portfolio context
Athyrium's portfolio includes notable companies across various sectors of healthcare, such as Agendia (Life Sciences Tools & Services), Alcresta (Health Care Equipment), Alvogen (Pharmaceutical), AMAG Pharmaceuticals (Pharmaceutical), Amryt Pharma (Biotechnology), Apollo Endosurgery (Health Care Equipment), AQUA Dermatology (Health Care Services), Basilea Pharmaceutica (Pharmaceutical), Coherus Biosciences (Biotechnology), Esperion Therapeutics (Pharmaceutical), Choice Health At Home (Health Care Services), Crown Laboratories (Pharmaceutical), and Omeros Corporation (Biotechnology).
Common questions
What to know about Athyrium Capital Management, LP
Upseed classifies Athyrium Capital Management, LP under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.